IMPROVUE  LUBRICANT- hypromellose 2208 (15000 mpa.s) solution/ drops 
Oculus Surgical, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

ImproVue®
Ophthalmic Lubricant Drops

Drug Facts

Active Ingredients

Hypromellose (1.7%)

Purpose

Ophthalmic Lubricant

Indications

Warnings

Stop use and ask a doctor if

  • If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a doctor.
  • If solution changes color or becomes cloudy, do not use.

Keep out of reach of children

  • If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other Information

Inactive Ingredients

Calcium chloride dihydrate, hydrochloric acid1, magnesium chloride hexahydrate, potassium chloride, purified water, sodium acetate trihydrate, sodium chloride, sodium citrate dihydrate, and sodium hydroxide1


1
May contain one or more of these ingredients for pH adjustment

Questions or Comments?

(855) 734-2466 or (772) 236-2622 or log onto www.oculussurgical.com

PRINCIPAL DISPLAY PANEL - 6 Pouch Carton

ImproVue®

Ophthalmic Lubricant Drops

Contains:

6 Pouches, each Pouch containing
1 Single Use Syringe, 0.07 fl oz (2 ml)
1 Single Use Applicator Tip

OCULUS®
SURGICAL
www.oculussurgical.com

Principal Display Panel - 6 Pouch Carton
IMPROVUE   LUBRICANT
hypromellose 2208 (15000 mpa.s) solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62144-5510
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYPROMELLOSE 2208 (15000 MPA.S) (UNII: Z78RG6M2N2) (HYPROMELLOSE 2208 (15000 MPA.S) - UNII:Z78RG6M2N2) HYPROMELLOSE 2208 (15000 MPA.S)17 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
Calcium Chloride (UNII: M4I0D6VV5M)  
Hydrochloric Acid (UNII: QTT17582CB)  
Magnesium Chloride (UNII: 02F3473H9O)  
Potassium Chloride (UNII: 660YQ98I10)  
Water (UNII: 059QF0KO0R)  
Sodium Acetate (UNII: 4550K0SC9B)  
Sodium Chloride (UNII: 451W47IQ8X)  
Trisodium Citrate Dihydrate (UNII: B22547B95K)  
Sodium Hydroxide (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:62144-5510-56 in 1 CARTON06/25/2014
11 in 1 POUCH
12 mL in 1 SYRINGE, PLASTIC; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34906/25/2014
Labeler - Oculus Surgical, Inc. (015409582)
Establishment
NameAddressID/FEIBusiness Operations
OASIS Medical, Inc.194121018MANUFACTURE(62144-5510)
Establishment
NameAddressID/FEIBusiness Operations
OASIS Medical, Inc.024362989PACK(62144-5510)

Revised: 2/2018
Document Id: 26e3210f-1bab-4ce6-8d9a-635c6c045deb
Set id: 63b82129-4848-47c5-bf92-ec4b1a9e9974
Version: 2
Effective Time: 20180201
 
Oculus Surgical, Inc.